FOXO4-DRI vs MOTS-c
Updated 8 sources
Key differences
- 1MOTS-c is a mitochondrial signal for energy metabolism; FOXO4-DRI kills senescent cells.
- 2Both are mouse-only for their main claims. Guides sequence MOTS-c after a FOXO4-DRI course.
Side by side
Facts from each record, in the same words as their own pages.
| FOXO4-DRI | MOTS-c | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms |
|
|
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
8 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study1
- PubMed search: MOTS-c pharmacokinetics or half-lifePubMed · checked Oct 23, 2026
Regulatory3
- FDA briefing document, PCAC July 23 to 24, 2026: MOTS-cFDA · checked Oct 23, 2026
- Bulk drug substances nominated for use in compounding under section 503A (interim categories 1 to 3)FDA · checked Oct 24, 2026
- Certain bulk drug substances for use in compounding that may present significant safety risksFDA · checked Oct 24, 2026
Competitor guide4
- FOXO4-DRI: the senolytic peptide that restored old mice in one studypeptidebreakdown.com · checked Oct 24, 2026
- FOXO4-DRI dosage guide: senolytic protocolspeptidewiki.co · checked Oct 24, 2026
- FOXO4-DRIpeptiq.io · checked Oct 24, 2026
- FOXO4-DRI quick start protocolpeptidedosingprotocols.com · checked Oct 24, 2026